Comparison of local corticosteroid injection and high-intensity laser outcomes in moderate carpal tunnel syndrome (CTS)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200219046552N1

Enrollment

126

Registered

2020-03-29

Start date

2020-04-20

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Control group: The splint will be prescribed with painkillers (meloxicam 15 mg) and vitamin B1. The splint should be used in neutral position for at least 8 hours a day for 3 months (n

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with unilateral or bilateral CTS according to Median Nerve Electrophysiology (EMG-NCV) studies will be enrolled.

Exclusion criteria

Exclusion criteria: History of wrist surgery, polyneuropathy, brachial plexopathy or thoracic outlet syndrome History of thrombocytopenia, platelet disorder, systemic infection, pregnancy and rheumatologic disorders. Previous injection of cortisone for treatment of CTS Thenar muscle atrophy

Design outcomes

Primary

Measure	Time frame
Symptom severity scale in Boston Carpal Tunnel Syndrome Questionnaire. Timepoint: Measurement of symptom severity at baseline and 6 months later. Method of measurement: Boston Carpal Tunnel Syndrome Questionnaire.;Functional status scale in Boston Carpal Tunnel Syndrome Questionnaire. Timepoint: Measurement of functional status at baseline and 6 months later. Method of measurement: Boston Carpal Tunnel Syndrome Questionnaire.	—

Measure

Time frame

Symptom severity scale in Boston Carpal Tunnel Syndrome Questionnaire. Timepoint: Measurement of symptom severity at baseline and 6 months later. Method of measurement: Boston Carpal Tunnel Syndrome Questionnaire.;Functional status scale in Boston Carpal Tunnel Syndrome Questionnaire. Timepoint: Measurement of functional status at baseline and 6 months later. Method of measurement: Boston Carpal Tunnel Syndrome Questionnaire.

—

Secondary

Measure	Time frame
Severity of pain. Timepoint: At baseline and 6 months after intervention. Method of measurement: Visual analog scale.;Distal sensory latency. Timepoint: At baseline and 6 months after intervention. Method of measurement: Based on the amount recorded by the EMG-NCV device.;Distal motor latency. Timepoint: At baseline and 6 months after intervention. Method of measurement: Based on the amount recorded by the EMG-NCV device.;Medical complications. Timepoint: 6 months after intervention. Method of measurement: Based on individual response.	—

Measure

Time frame

Severity of pain. Timepoint: At baseline and 6 months after intervention. Method of measurement: Visual analog scale.;Distal sensory latency. Timepoint: At baseline and 6 months after intervention. Method of measurement: Based on the amount recorded by the EMG-NCV device.;Distal motor latency. Timepoint: At baseline and 6 months after intervention. Method of measurement: Based on the amount recorded by the EMG-NCV device.;Medical complications. Timepoint: 6 months after intervention. Method of measurement: Based on individual response.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozaffar Hosseininezhad

Rasht University of Medical Sciences

hosseininezhadm@gmail.com+98 13 3332 2444

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026